{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:29:48Z","timestamp":1791073788161,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":518,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/bjd.12778","type":"journal-article","created":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T07:38:38Z","timestamp":1387006718000},"page":"914-921","source":"Crossref","is-referenced-by-count":65,"title":["The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis"],"prefix":"10.1093","volume":"170","author":[{"given":"S.G.","family":"Danby","sequence":"first","affiliation":[{"name":"The Academic Unit of Dermatology Research; Department of Infection and Immunity; Faculty of Medicine, Dentistry and Health; The University of Sheffield Medical School; Beech Hill Road Sheffield S10 2RX U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chittock","sequence":"additional","affiliation":[{"name":"The Academic Unit of Dermatology Research; Department of Infection and Immunity; Faculty of Medicine, Dentistry and Health; The University of Sheffield Medical School; Beech Hill Road Sheffield S10 2RX U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brown","sequence":"additional","affiliation":[{"name":"The Academic Unit of Dermatology Research; Department of Infection and Immunity; Faculty of Medicine, Dentistry and Health; The University of Sheffield Medical School; Beech Hill Road Sheffield S10 2RX U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.H.","family":"Albenali","sequence":"additional","affiliation":[{"name":"The Academic Unit of Dermatology Research; Department of Infection and Immunity; Faculty of Medicine, Dentistry and Health; The University of Sheffield Medical School; Beech Hill Road Sheffield S10 2RX U.K"},{"name":"Kuwait Ministry of Health; Kuwait City Kuwait"},{"name":"The Paediatric Dermatology Clinic; Sheffield Children's Hospital; Sheffield U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cork","sequence":"additional","affiliation":[{"name":"The Academic Unit of Dermatology Research; Department of Infection and Immunity; Faculty of Medicine, Dentistry and Health; The University of Sheffield Medical School; Beech Hill Road Sheffield S10 2RX U.K"},{"name":"The Paediatric Dermatology Clinic; Sheffield Children's Hospital; Sheffield U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,15]]},"reference":[{"key":"10.1111\/bjd.12778-BIB0001|bjd12778-cit-0001","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12778-BIB0002|bjd12778-cit-0002","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2133.2010.10068.x","article-title":"Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3\u00a0months of age","volume":"163","author":"Flohr","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12778-BIB0003|bjd12778-cit-0003","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2007.12.1161","article-title":"Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity","volume":"121","author":"Gupta","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12778-BIB0004|bjd12778-cit-0004","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2008.08.002","article-title":"Filaggrin in atopic dermatitis","volume":"122","author":"O'Regan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12778-BIB0005|bjd12778-cit-0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1111\/bjd.12778-BIB0006|bjd12778-cit-0006","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1398-9995.2010.02540.x","article-title":"Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity","volume":"66","author":"Kezic","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/bjd.12778-BIB0007|bjd12778-cit-0007","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/jid.2008.280","article-title":"Clinical severity correlates with impaired barrier in filaggrin-related eczema","volume":"129","author":"Nemoto-Hasebe","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12778-BIB0008|bjd12778-cit-0008","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1067\/mai.2002.121832","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12778-BIB0009|bjd12778-cit-0009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.2010.10030.x","article-title":"Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials","volume":"164","author":"Schmitt","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12778-BIB0010|bjd12778-cit-0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12778-BIB0011|bjd12778-cit-0011","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1185\/03007995.2011.582483","article-title":"A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis","volume":"27","author":"Svensson","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/bjd.12778-BIB0012|bjd12778-cit-0012","unstructured":"Cork MJ Varghese J Sultan A et\u00a0al Therapeutic implications of the differential effects of topical corticosteroids and calcineurin inhibitors on the skin barrier 5th George Rajka International Symposium on Atopic Dermatitis (ISAD)"},{"key":"10.1111\/bjd.12778-BIB0013|bjd12778-cit-0013","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12778-BIB0014|bjd12778-cit-0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.1996.tb03599.x","article-title":"Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party","volume":"135","author":"Williams","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12778-BIB0015|bjd12778-cit-0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.2011.10395.x","article-title":"The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis","volume":"165","author":"Danby","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12778-BIB0016|bjd12778-cit-0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0846.2007.00214.x","article-title":"Efficient and simple quantification of stratum corneum proteins on tape strippings by infrared densitometry","volume":"13","author":"Voegeli","year":"2007","journal-title":"Skin Res Technol"},{"key":"10.1111\/bjd.12778-BIB0017|bjd12778-cit-0017","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1467-2494.2007.00386.x","article-title":"Profiling of serine protease activities in human stratum corneum and detection of a stratum corneum tryptase-like enzyme","volume":"29","author":"Voegeli","year":"2007","journal-title":"Int J Cosmet Sci"},{"key":"10.1111\/bjd.12778-BIB0018|bjd12778-cit-0018","unstructured":"National Institute for Health and Care Excellence Atopic eczema in children - guideline consultation http:\/\/www.nice.org.uk\/guidance\/index.jsp?action=folder&r=true&o=34271"},{"key":"10.1111\/bjd.12778-BIB0019|bjd12778-cit-0019","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2133.1997.tb03929.x","article-title":"Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids","volume":"136","author":"Sheu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12778-BIB0020|bjd12778-cit-0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1346-8138.1991.tb03115.x","article-title":"Modulation of epidermal terminal differentiation in patients after long-term topical corticosteroids","volume":"18","author":"Sheu","year":"1991","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.12778-BIB0021|bjd12778-cit-0021","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1600-0625.2011.01335.x","article-title":"Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography","volume":"20","author":"Aschoff","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12778-BIB0022|bjd12778-cit-0022","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2133.2006.07369.x","article-title":"Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry: a double-blind, placebo-controlled trial","volume":"155","author":"Cossmann","year":"2006","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/bjd.12778-BIB0023|bjd12778-cit-0023","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1016\/j.jaci.2009.07.015","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"124","author":"Jensen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12778-BIB0024|bjd12778-cit-0024","doi-asserted-by":"crossref","DOI":"10.1111\/srt.12095","article-title":"Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus","author":"Shlivko","year":"2013","journal-title":"Skin Res Technol"},{"key":"10.1111\/bjd.12778-BIB0025|bjd12778-cit-0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0625.2011.01417.x","article-title":"The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions","volume":"21","author":"Grzanka","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12778-BIB0026|bjd12778-cit-0026","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1398-9995.2011.02747.x","article-title":"Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis","volume":"67","author":"Jensen","year":"2012","journal-title":"Allergy"},{"key":"10.1111\/bjd.12778-BIB0027|bjd12778-cit-0027","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.12778-BIB0028|bjd12778-cit-0028","unstructured":"Lloyd D Prescription cost analysis - England 2011 http:\/\/www.hscic.gov.uk\/catalogue\/PUB05807\/pres-cost-anal-eng-2011-rep.pdf"},{"issue":"Suppl. 2","key":"10.1111\/bjd.12778-BIB0029|bjd12778-cit-0029","first-page":"AB69","article-title":"The effects of topical corticosteroids and pimecrolimus on skin barrier function, gene expression and topical drug penetration in atopic eczema and unaffected controls","volume":"56","author":"Cork","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.12778-BIB0030|bjd12778-cit-0030","first-page":"S45","article-title":"Differences in the effect of topical corticosteroids and calcineurin inhibitors on the skin barrier - implications for therapy","volume":"127","author":"Cork","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12778-BIB0031|bjd12778-cit-0031","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0625.2009.00841.x","article-title":"Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis","volume":"18","author":"Demerjian","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.12778-BIB0032|bjd12778-cit-0032","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00128071-200405040-00002","article-title":"Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus","volume":"5","author":"Rippke","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12778-BIB0033|bjd12778-cit-0033","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.0022-202X.2005.23838.x","article-title":"Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity","volume":"125","author":"Hachem","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12778-BIB0034|bjd12778-cit-0034","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/jid.2009.435","article-title":"Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid","volume":"130","author":"Morizane","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12778-BIB0035|bjd12778-cit-0035","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.12778-BIB0036|bjd12778-cit-0036","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.157.4.1699","article-title":"IL-1 beta activation in human epidermis","volume":"157","author":"Nylander-Lundqvist","year":"1996","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12778-BIB0037|bjd12778-cit-0037","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1600-0625.2007.00562.x","article-title":"Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients","volume":"16","author":"Komatsu","year":"2007","journal-title":"Exp Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.12778-BIB0038|bjd12778-cit-0038","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jaad.2005.04.027","article-title":"Mechanisms of action of topical therapies and the rationale for combination therapy","volume":"53","author":"Norris","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12778","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12778\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T00:48:00Z","timestamp":1688863680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/170\/4\/914\/6614764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12778","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}